Virtual Investor: Moleculin Doses First Patient in Phase 2 Study for AML - Form 8-K -October 17, 2023 at 09:03 am EDT

Virtual Investor: Moleculin Doses First Patient in Phase 2 Study for AML


Participants:







●

...

Related Keywords

Jenene Thomas ,Wally Klemp ,Moleculin Bio ,Walter Klemp ,Exchange Commission ,Nasdaq ,Virtual Investor ,Moleculin Doses First Patient ,Chief Executive Officer ,Moleculin Biotech ,Chief Executive ,Soft Tissue Sarcomas ,Virtual Investor What ,Markets ,